-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Nfeo94xbGDQpKh5T8xByggpi94aaMnEntzco482SE7OlQvGu8dw7ClA7QdOh2y5z rBADRTZR7vd49opOAKTzig== 0000919574-02-000498.txt : 20020414 0000919574-02-000498.hdr.sgml : 20020414 ACCESSION NUMBER: 0000919574-02-000498 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20020214 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: LEVITAS JAMES R CENTRAL INDEX KEY: 0001034254 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 230 PARK AVENUE SUITE 1549 CITY: NEW YORK STATE: NY ZIP: 10169 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: AMEDISYS INC CENTRAL INDEX KEY: 0000896262 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HOME HEALTH CARE SERVICES [8082] IRS NUMBER: 113131700 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-48126 FILM NUMBER: 02546695 BUSINESS ADDRESS: STREET 1: 11100 MEAD ROAD STE 300 CITY: BATON ROUGE STATE: LA ZIP: 70816 BUSINESS PHONE: 2252922031 MAIL ADDRESS: STREET 1: 11100 MEAD ROAD STE 300 CITY: BATON ROUGE STATE: LA ZIP: 70816 FORMER COMPANY: FORMER CONFORMED NAME: M&N CAPITAL CORP DATE OF NAME CHANGE: 19930125 FORMER COMPANY: FORMER CONFORMED NAME: ANALYTICAL NURSING MANAGEMENT CORP DATE OF NAME CHANGE: 19940819 SC 13G/A 1 le00501001ag2.txt UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 Amendment No.: 1 Name of Issuer: Amedisys, Inc. Title of Class of Securities: Common Stock, $0.001 par value CUSIP Number: 023436108 (Date of Event Which Requires Filing of this Statement) December 31, 2001 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: / / Rule 13d-1(b) /X/ Rule 13d-1(c) / / Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP Number: 023436108 1. Name of Reporting Person I.R.S. Identification No. of Above Person James R. Levitas 2. Check the Appropriate Box if a Member of a Group a. b. X 3. SEC Use Only 4. Citizenship or Place of Organization United States Number of Shares Beneficially Owned by Each Reporting Person With: 5. Sole Voting Power: 53,800 6. Shared Voting Power: 192,000 7. Sole Dispositive Power: 192,000 8. Shared Dispositive Power: 192,000 9. Aggregate Amount Beneficially Owned by Each Reporting Person 245,800 10. Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares 2 11. Percent of Class Represented by Amount in Row (9) 4.16% 12. Type of Reporting Person IN 3 CUSIP Number: 023436108 1. Name of Reporting Person I.R.S. Identification No. of Above Person LEVCO Partners, L.P. 2. Check the Appropriate Box if a Member of a Group a. b. X 3. SEC Use Only 4. Citizenship or Place of Organization Delaware Number of Shares Beneficially Owned by Each Reporting Person With: 5. Sole Voting Power: 0 6. Shared Voting Power: 192,000 7. Sole Dispositive Power: 0 8. Shared Dispositive Power: 192,000 9. Aggregate Amount Beneficially Owned by Each Reporting Person 192,000 10. Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares 11. Percent of Class Represented by Amount in Row (9) 3.25% 4 12. Type of Reporting Person ` PN 5 Item 1(a) Name of Issuer: Amedisys, Inc. (b) Address of Issuer's Principal Executive Offices: 11100 Mead Road, Suite 300 Baton Rouge, LA 70816 Item 2(a) - (c). Name, Principal Business Address, and Citizenship of Persons Filing: James R. Levitas c/o Levitas & Company 230 Park Avenue, Suite 1549 New York, New York 10169 LEVCO Partners, L.P. c/o 230 Park Avenue, Suite 1549 New York, New York 10169 James R. Levitas - United States Citizen LEVCO Partners, L.P. - Delaware Limited Partnership (d) Title of Class of Securities: Common Stock, $0.001 par value (e) CUSIP Number: 023436108 Item 3. If this statement is filed pursuant to Rule 13d-1(b)(1) or 13d-2(b) or (c) check whether the person filing is: (a) / / Broker or dealer registered under Section 15 of the Act, (b) / / Bank as defined in Section 3(a)(6) of the Act, (c) / / Insurance Company as defined in Section 3(a)(19) of the Act, (d) / / Investment Company registered under Section 8 of the Investment Company Act, (e) / / Investment Adviser registered under Section 203 of the Investment Advisers Act of 1940, (f) / / Employee Benefit Plan, Pension Fund which is subject to the provisions of the Employee Retirement Income Security Act of 1974 or Endowment Fund, 6 (g) / / Parent Holding Company, in accordance with Rule 13d-1(b)(ii)(G), (h) / / Savings association as defined in Section 3(b) of the Federal Deposit Insurance Act, (i) / / Church plan excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act, (j) / / Group, in accordance with Rule 13d- 1(b)(1)(ii)(H). If this statement is filed pursuant to Rule 13d-1(c), check this box. /X/ Item 4. Ownership. (a) Amount Beneficially Owned: James R. Levitas: 245,800 shares; LEVCO Partners, L.P.: 192,000 shares (b) Percent of Class: James R. Levitas: 4.16% LEVCO Partners, L.P.: 3.25% (c) James R. Levitas: 245,800 shares with shared power to vote or to direct the vote; 53,800 shares with sole power to vote or to direct the vote; 192,000 shares with shared power to dispose or to direct the disposition of; 53,800 shares with the sole power to dispose or to direct the disposition of LEVCO Partners, L.P.: 192,000 shares with shared power to vote or to direct the vote; 0 shares with sole power to vote or to direct te vote; 192,000 shares with shared power to dispose or to direct the disposition of ; 0 shares with the sole power to dispose or to direct the disposition of Item 5. Ownership of Five Percent or Less of a Class. If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following /X/. Item 6. Ownership of More than Five Percent on Behalf of Another Person. 7 N/A Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported by the Parent Holding Company. N/A Item 8. Identification and Classification of Members of the Group. N/A Item 9. Notice of Dissolution of the Group. N/A Item 10. Certification for Rule 13d-1(c): By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. LEVCO Partners, L.P. LEVITAS & COMPANY General Partner By:/s/ James R. Levitas _________________________ James R. Levitas President /s/ James R. Levitas _________________________ James R. Levitas February 14, 2002 8 __________________ Date 9 AGREEMENT The undersigned agree that this Schedule 13G dated February 14, 2002 relating to the Common Stock $0.001 par value of Amedisys, Inc. shall be filed on behalf of the undersigned. LEVCO Partners, L.P. LEVITAS & COMPANY General Partner By:/s/ James R. Levitas _________________________ James R. Levitas President 10 00501001.AG2 -----END PRIVACY-ENHANCED MESSAGE-----